As the global economy mends, the 2021 growth of Fasudil will have significant change from previous year. According to our (LP Information) latest study, the global Fasudil market size is USD million in 2022 from USD million in 2021, with a change of % between 2021 and 2022. The global Fasudil market size will reach USD million in 2028, growing at a CAGR of % over the analysis period.
The United States Fasudil market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Fasudil market, reaching US$ million by the year 2028. As for the Europe Fasudil landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.
Global main Fasudil players cover Asahi Kasei, Grand Pharmaceutical, Sichuan Meida Kangjiale Pharmaceutical, and Tianjin Hongri Pharmaceutical, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of Fasudil market by product type, application, key manufacturers and key regions and countries.
Segmentation by type: breakdown data from 2017 to 2022, in Section 2.3; and forecast to 2028 in section 12.6
Interventional Therapy
Intravenous Drip
Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 12.7.
Cerebral Vasospasm
Pulmonary Hypertension
Alzheimer's Disease
Other
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the prominent manufacturers in this market, include
Asahi Kasei
Grand Pharmaceutical
Sichuan Meida Kangjiale Pharmaceutical
Tianjin Hongri Pharmaceutical
Tianjin Jinyao Pharmaceutical
Shandong Luoxin Pharmaceutical Group
Shanxi Pude Pharmaceutical
Guangzhou Baiyunshan Tianxin Pharmaceutical
Chengdu Yuandong Biological Pharmaceutical
Jiangsu Disanuo Pharmaceutical
Qilu Pharmaceutical
Wuhan Qirui Pharmaceutical
Xinhua Pharmaceutical